Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-573 inhibits cell proliferation, migration and invasion and is downregulated by PICSAR in cutaneous squamous cell carcinoma. | Bosn J Basic Med Sci | 2022 | 34905724 | PubTator, text mining | PubMed |
| Tumor immune microenvironment lncRNAs. | Brief Bioinform | 2022 | 34891154 | PubTator, text mining | PubMed |
| Non-coding RNAs underlying the pathophysiological links between type 2 diabetes and pancreatic cancer: A systematic review. | J Diabetes Investig | 2022 | 34859606 | PubTator, text mining | PubMed |
| Eph signaling is regulated by miRNA-210: Implications for corneal epithelial repair. | FASEB J | 2022 | 34856019 | PubTator, text mining | PubMed |
| MicroRNAs as potential therapeutic targets for pancreatic cancer. | Chin Med J (Engl) | 2022 | 34839317 | PubTator, text mining | PubMed |
| Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes-Associated Protein 1 Activation and Transient Expansion of Stem-Like Cancer Cells. | Hepatol Commun | 2022 | 34817932 | PubTator, text mining | PubMed |
| NEAT1 promotes proliferation of NSCLC cells via regulating miR-377-3p/E2F3. | Minerva Surg | 2022 | 34790914 | PubTator, text mining | PubMed |
| Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review. | Int J Cancer | 2022 | 34706070 | PubTator, text mining | PubMed |
| Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer. | J Pathol Clin Res | 2022 | 34697907 | PubTator, text mining | PubMed |
| Detection of Neanderthal Adaptively Introgressed Genetic Variants That Modulate Reporter Gene Expression in Human Immune Cells. | Mol Biol Evol | 2022 | 34662402 | PubTator, text mining | PubMed |
| Systematic study on expression and prognosis of E2Fs in human colorectal cancer. | Int J Clin Oncol | 2022 | 34661779 | PubTator, text mining | PubMed |
| Expression of Concern: Knockdown of long non-coding RNA LINC00467 inhibits glioma cell progression via modulation of E2F3 targeted by miR-200a. | Cell Cycle | 2022 | 34634218 | PubTator, text mining | PubMed |
| Genetic associated complications of type 2 diabetes mellitus. | Panminerva Med | 2022 | 34609116 | PubTator, text mining | PubMed |
| Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2022 | 34569195 | PubTator, text mining | PubMed |
| Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure. | Int J Cancer | 2022 | 34569060 | PubTator, text mining | PubMed |
| Circ-E2F3 promotes cervical cancer progression by inhibiting microRNA-296-5p and increasing STAT3 nuclear translocation. | Ann N Y Acad Sci | 2022 | 34468993 | PubTator, text mining | PubMed |
| MiR-493-5p inhibits the malignant development of gliomas via suppressing E2F3-mediated dysfunctions of P53 and PI3K/AKT pathways. | Clin Transl Oncol | 2022 | 34460057 | PubTator, text mining | PubMed |
| Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA-152-3p and regulating E2F3/MAPK8 signaling. | Cancer Sci | 2022 | 34418232 | PubTator, text mining | PubMed |
| The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma. | Mol Oncol | 2022 | 34080276 | PubTator, text mining | PubMed |
| Characterizing the molecular and immune landscape of canine bladder cancer. | Vet Comp Oncol | 2022 | 34021685 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=41